- Home
- ELME vs JANX Comparison
ELME vs JANX Comparison
Compare ELME & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELME
- JANX
- Stock Information
- Founded
- ELME 1960
- JANX 2017
- Country
- ELME United States
- JANX United States
- Employees
- ELME N/A
- JANX N/A
- Industry
- ELME Real Estate Investment Trusts
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- ELME Real Estate
- JANX Health Care
- Exchange
- ELME Nasdaq
- JANX Nasdaq
- Market Cap
- ELME 1.4B
- JANX 1.4B
- IPO Year
- ELME N/A
- JANX 2021
- Fundamental
- Price
- ELME $16.58
- JANX $24.97
- Analyst Decision
- ELME Hold
- JANX Strong Buy
- Analyst Count
- ELME 6
- JANX 8
- Target Price
- ELME $18.20
- JANX $90.63
- AVG Volume (30 Days)
- ELME 1.3M
- JANX 892.8K
- Earning Date
- ELME 08-05-2025
- JANX 08-07-2025
- Dividend Yield
- ELME 4.33%
- JANX N/A
- EPS Growth
- ELME N/A
- JANX N/A
- EPS
- ELME N/A
- JANX N/A
- Revenue
- ELME $245,911,000.00
- JANX $439,000.00
- Revenue This Year
- ELME $4.84
- JANX N/A
- Revenue Next Year
- ELME $0.80
- JANX $1,470.83
- P/E Ratio
- ELME N/A
- JANX N/A
- Revenue Growth
- ELME 4.59
- JANX N/A
- 52 Week Low
- ELME $13.95
- JANX $21.97
- 52 Week High
- ELME $18.49
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- ELME 58.26
- JANX 52.30
- Support Level
- ELME $16.31
- JANX $21.97
- Resistance Level
- ELME $16.65
- JANX $25.93
- Average True Range (ATR)
- ELME 0.33
- JANX 1.61
- MACD
- ELME 0.08
- JANX 0.02
- Stochastic Oscillator
- ELME 91.19
- JANX 60.84
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.